Answers are grounded in this paper and cite their sources.
Background Acromegaly has an insidious onset and prolonged diagnostic delay. Vocal changes are a recognized clinical feature, the diagnostic value of deep learning architectures remains underexplored. We aimed to assess Wav2Vec2.0-based voice analysis as a non-invasive digital biomarker for acromegaly. Methods This single-center case-control study included 70 patients with acromegaly and 68 age- and sex-matched controls. Clinical status was defined by standard biochemical criteria, symptoms, comorbidities, and residual tumor. Voice samples were recorded with a standard mobile phone and resampled to 16 kHz. Wav2Vec2.0 was used to extract high-dimensional embedding vectors. These embeddings, were used to train and validate four different machine learning classifiers using an 80%/20% train–test split with five-fold cross-validation. Model calibration was assessed with the Brier score, and clinical utility with decision curve analysis (DCA). Results Demographics were similar between acromegaly (mean age 45.5 years; 57.1% female) and control (mean age 47.5 years; 61.8% female) groups. In five-fold cross-validation, Logistic Regression(LR) performed best, with an AUC of 0.86 (95% CI: 0.79–0.93), sensitivity 0.73 (0.57–0.90), and specificity 0.79 (0.72–0.87). On the test set, LR maintained high accuracy (AUC 0.84; specificity 0.92; sensitivity 0.71) and showed good calibration (Brier score 0.1753). DCA confirmed that LR provided the highest benefit across a clinically relevant range of threshold probabilities (~ 15–85%). Conclusion Voice analysis Wav2Vec2.0-based model demonstrates good diagnostic accuracy for acromegaly. These preliminary findings suggest that voice may serve as a promising non-invasive digital biomarker, pending validation in larger and more diverse cohorts.
No takes yet. Share an insight, caveat, or question.
Aksoy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: